CRLF2 and WT1 overexpression were detected in 4 patients diagnosed with ALL (15.4%, 2 with B-ALL and 2 with T-ALL) and in 3 patients diagnosed with AML (11.5%). This evidence concerns the gene WT1 and acute myeloid leukemia.